PDCD1 and hepatocellular carcinoma: In addition, in an orthotopic HCC mouse model, the combined vaccination with DCs and treatment with a PD-1 inhibitor had a longer overall survival and more effective reduction in tumor volume compared to monotherapy with the PD-1 inhibitor [178] (Table 1).